================================================================================

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB

|X|   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
      EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2005; OR

|_|   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
      EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM
                          ____________ TO ____________

                         Commission file number: 0-28793

                              OSK CAPITAL III CORP.

             (Exact name of registrant as specified in its charter)


            Nevada                                    84-1491673
(State or other jurisdiction of          (I.R.S. Employer Identification No.)
incorporation or organization)


               One Concourse Parkway, Suite 600, Atlanta, GA 30328
              -------------------------------------------------------
               (Address of principal executive offices)    (Zip Code)


        Registrant's telephone number, including area code: 770-673-6656


        1 Place Ville-Marie, Suite 2821, Montreal, Quebec Canada H3B 4R4
        ----------------------------------------------------------------
          (Former name or former address, if changed from last report)

       Copies of all communications, including all communications sent to the
agent for service, should be sent to:

                         Joseph I. Emas, Attorney at Law
                             1224 Washington Avenue
                           Miami Beach, Florida 33139
                             Telephone: 305.531.1174
       Securities registered under Section 12(b) of the Exchange Act: None

         Securities registered under Section 12(g) of the Exchange Act:

                                  COMMON STOCK
                                (Title of Class)

<PAGE>

Check whether the issuer (1) has filed all reports required to be filed by
Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such
shorter period Indicate by check mark whether the registrant (1) has filed all
reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. |X| Yes |_|  No

As of June 16, 2005, there were 3,326,000 shares of the registrant's common
stock outstanding.

<PAGE>

                              OSK CAPITAL III CORP.

                          (A DEVELOPMENT STAGE COMPANY)

                         CONDENSED FINANCIAL STATEMENTS

                                 March 31, 2005

                                TABLE OF CONTENTS

                                                                         Page
                                                                      --------
Condensed Balance Sheets.....................................................2
Condensed Statements of Operations...........................................3
Condensed Statements of Cash Flows...........................................4
Notes to Condensed Financial Statements......................................5
<PAGE>


                              OSK CAPITAL III CORP.
                         (A DEVELOPMENT STAGE COMPANY)
                            CONDENSED BALANCE SHEETS

                                                                      March 31,
                                                                        2005
                                                                     (Unaudited)
                                     ASSETS
Cash                                                                   $    395
                                                                       --------

  TOTAL ASSETS                                                         $    395
                                                                       ========

                      LIABILITIES AND STOCKHOLDERS' DEFICIT
Accounts payable                                                       $  2,538

   TOTAL LIABILITIES                                                   $  2,538

STOCKHOLDERS' DEFICIT                                                     3,326
Capital stock                                                            77,582
Additionial paid-in capital                                             (83,051)
Accumulated deficit                                                      (2,143)
   TOTAL STOCKHOLDERS' DEFICIT
  TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT                          $    395


The accompanying notes are an integral part of these financial statements.



                                       2
<PAGE>

                              OSK CAPITAL III CORP.
                         (A DEVELOPMENT STAGE COMPANY)
                       CONDENSED STATEMENTS OF OPERATIONS

<TABLE>
<CAPTION>
                                                                             June 2, 2000
                                                                             (Inception)
                                                Three Months Ended March 31,  March 31,
                                                -------------------------    ------------
                                                    2005         2004           2005
                                               -----------    -----------    -----------
                                                (Unaudited)   (Unaudited)
<S>                                            <C>            <C>            <C>
Revenues
                                               $        --    $        --    $        --
Operating expenses
  General and administrative expenses                  175          1,887            175
  Professional fees                                  1,000             --         82,741
  Other expenses                                        --             --            135
                                               -----------    -----------    -----------
  NET LOSS
                                               $    (1,175)   $    (1,887)   $   (83,051)
                                               ===========    ===========    ===========
Net loss per common share
                                               $    (0.000)   $    (0.001)   $    (0.025)
                                               ===========    ===========    ===========
Weighted average number of common shares
  used in calculation                            3,329,068      3,316,000      3,329,068
                                               ===========    ===========    ===========
</TABLE>

The accompanying notes are an integral part of these financial statements.



                                       3
<PAGE>

                              OSK CAPITAL III CORP.
                         (A DEVELOPMENT STAGE COMPANY)
                       CONDENSED STATEMENTS OF CASH FLOWS

<TABLE>
<CAPTION>
                                                                                        June 2, 2000
                                                                                         (Inception)
                                                    Three Months Ended March 31,           March 31,
                                                ----------------------------------    ---------------
                                                    2005                  2004                2005
                                                ---------------    ---------------    ---------------
                                                   (Unaudited)        (Unaudited)
<S>                                             <C>                <C>                <C>
Cash Flows from Operating Activities
    Net loss
                                                $        (1,175)   $        (1,887)   $       (83,051)
  Issue of common stock for services                     60,910
  Change in accounts payable                                 --                (38)             2,538
                                                ---------------    ---------------    ---------------
  Net cash flows used in operating activities            (1,175)            (1,925)           (19,603)
                                                ---------------    ---------------    ---------------
Cash Flows from Investing Activities
  Net cash used by investing activities                      --                 --                 --
                                                ---------------    ---------------    ---------------
Cash Flows from Financing Activities
  Issue of common stock                                   6,770
  Shareholder contributions                                  --              1,800             13,228
                                                ---------------    ---------------    ---------------
  Net cash used by financing activities                      --              1,800             19,998
                                                ---------------    ---------------    ---------------
Net increase (decrease) in cash                          (1,175)              (125)               395
Cash - Beginning of period                                1,570              1,739                 --
                                                ---------------    ---------------    ---------------
Cash - Ending of period
                                                $           395    $         1,614    $           395
                                                ===============    ===============    ===============
</TABLE>

   The accompanying notes are an integral part of these financial statements.


                                       4
<PAGE>

                              OSK CAPITAL III CORP.

                          (A DEVELOPMENT STAGE COMPANY)

                     NOTES TO CONDENSED FINANCIAL STATEMENTS

                                 March 31, 2005

NOTE 1 - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Organization

The Company was incorporated in the State of Nevada on March 26, 1999 to serve
as a vehicle to effect an asset acquisition, merger, exchange of capital stock
or other business combination with a domestic or foreign business. As of March
31, 2005, the Company's only activities have been organizational ones, directed
at developing its business plan and raising its initial capital.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Interim Financial Statements

The accompanying interim unaudited financial information has been prepared
pursuant to the rules and regulations of the Securities and Exchange Commission.
Certain information and footnote disclosures normally included in financial
statements prepared in accordance with accounting principles generally accepted
in the United States of America have been condensed or omitted pursuant to such
rules and regulations, although management believes that the disclosures are
adequate to make the information presented not misleading. In the opinion of
management, all adjustments, consisting only of normal recurring adjustments,
necessary to present fairly the financial position of the Company as of March
31, 2005 and the related operating results and cash flows for the interim period
presented have been made. The results of operations of such interim period are
not necessarily indicative of the results of the full year.

NOTE 3 - COMMITMENTS AND CONTINGENCIES

On March 14, 2005 the Company completed the acquisition of Ideal Medical Inc., a
Texas corporation, pursuant to an Agreement and Plan of Merger. At the effective
time of the merger Ideal Medical Inc. will be merged with and into our wholly
owned subsidiary, OSK Acquisition Corp., a Florida corporation, which will be
subsequently dissolved and merged into the company.

All of the outstanding shares of Ideal Medical Inc. common stock shall be
converted by virtue of the merger at the Closing Date into shares of our common
stock (the "Merger Securities"). On or before the Closing Date, March 30, 2005,
each Shareholder of Ideal Medical Inc. shall surrender their outstanding shares
of Ideal Medical Inc. common stock existing immediately prior to the Closing
Date. Until surrendered, any outstanding certificates or other documentation
which, prior to the Closing Date represented outstanding shares of Ideal Medical
Inc. common stock, shall be deemed for all corporate purposes to be surrendered.
Upon such surrender, shares of Ideal Medical Inc. common stock so surrendered
shall no longer be outstanding and shall automatically be canceled and retired
and shall cease to exist. Following the completion of the reverse merger
transaction on March 30, 2005, a change of control will occur.

<PAGE>

                     MANAGEMENT'S DISCUSSION AND ANALYSIS OF
                  FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The previous discussion and other sections of this Form 10-QSB contain
forward-looking statements that have been made pursuant to the provisions of the
Private Securities Litigation Reform Act of 1995. These forward-looking
statements are based on current expectations, estimates and projections about
our industry, management's beliefs and certain assumptions made by management.
Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks,"
"estimates," "may," and similar expressions are intended to identify
forward-looking statements. These statements are not guarantees of future
performance and actual actions or results may differ materially. These
statements are subject to certain risks, uncertainties and assumptions that are
difficult to predict. The Company undertakes no obligation to update publicly
any forward-looking statements as a result of new information, future events or
otherwise, unless required by law. Readers should, however, carefully review the
risk factors included in other reports or documents filed by the Company from
time to time with the Securities and Exchange Commission.

The Company was incorporated under the laws of the State of Nevada on March 2,
1999, and is in the early developmental and promotional stages. To date, the
Company's only activities have been organizational ones, directed at developing
its business plan and raising its initial capital. The Company has not commenced
any commercial operations. The Company has no full-time employees and owns no
real estate.

At of the end of its fiscal year ending December 31, 2003, the Company has not
identified any business opportunity that it plans to pursue, nor has the Company
reached any agreement or definitive understanding with any person concerning an
acquisition.

No assurance can be given that the Company will be successful in finding or
acquiring a desirable business opportunity, given the limited funds that are
expected to be available for acquisitions, or that any acquisition that occurs
will be on terms that are favorable to the Company or its stockholders.

The Company's search has been directed toward enterprises which have a desire to
be become a public corporation and which have a business plan designed to allow
them to take advantage of opportunities available to public entities. This
includes entities which have been recently organized, with no operating history,
or a history of losses attributable to under- capitalization or other factors,
entities in need of funds to develop a new product or service or to expand into
a new market, entities which desire to use their securities to make
acquisitions, and entities which have a combination of these characteristics.

In searching for investment opportunities, the Company is not restricted to any
particular geographical area or industry. Therefore, subject to economic
conditions, limitations on its ability to locate available business
opportunities, and other factors, the Company has substantial discretion in
selecting an appropriate business opportunity.

In connection with any acquisition, it is highly likely that an amount of stock
constituting control of the Company would be issued by the Company or purchased
from the Company's current principal shareholders by the target entity or its
controlling shareholders.

On March 14, 2005, we completed our acquisition of Ideal Medical Inc., a Texas
corporation, pursuant to an Agreement and Plan of Merger, the form of which is
attached as Exhibit 2.1 hereto. At the effective time of the merger, Ideal
Medical Inc. will be merged with and into our wholly owned subsidiary, OSK
Acquisition Corp., a Florida corporation, which will be subsequently dissolved
and merged into our company. On March 28, 2005, we determined that the Closing
Date shall be March 30, 2005.

All of the outstanding shares of Ideal Medical Inc. common stock shall be
converted by virtue of the merger at the Closing Date into shares of our common
stock (the "Merger Securities"). On or before the Closing Date, March 30, 2005,
each Shareholder of Ideal Medical Inc. shall surrender their outstanding shares
of Ideal Medical Inc. common stock existing immediately prior to the Closing
Date. Until so surrendered, any outstanding certificates or other documentation
which, prior to the Closing Date represented outstanding shares of Ideal Medical
Inc. common stock, shall be deemed for all corporate purposes to be surrendered.
Upon such surrender, shares of Ideal Medical Inc. common stock so surrendered
shall no longer be outstanding and shall automatically be canceled and retired
and shall cease to exist.

Other Entities

    The previous directors and principal shareholders of the Company are also
the officers, directors and principal shareholders of eight other corporations
which were formed at the same time as the Company. Each of these other
corporations has the same business plan as the Company. On March 16, 2005 Frank
Kramer and Deborah Salerno resigned as officers of OSK CAPITAL III CORP. and
resigned as members of the Board of Directors of the Company. Further to the
resignation of Ms. Salerno and Mr. Kramer, Francis Mailhot remains the sole
director and has been nominated as President and CEO of the Company.
<PAGE>

On April 7, 2005, Mr. Francis Mailhot resigned as President and CEO of the
Company. Mr. Francis Mailhot will remain as a director of the Company.

On April 7, 2005, Mr. Roger Morlan, Ms. Myra Batista and Ms. Angela Buffa have
been appointed as directors of the Company.

Ms. Angela Buffa has been appointed as President and CEO of the Company.

The Company currently maintains a mailing address at 1 Place Ville-Marie, Suite
2821, Montreal, Quebec Canada H3B 4R4. Other than this mailing address, the
Company does not currently maintain any other office facilities, and does not
anticipate the need for maintaining office facilities at any time in the
foreseeable future. The Company pays no rent or other fees for the use of this
mailing address.

RESULTS OF OPERATIONS

Three Months Ended March 31, 2005.

As of March 31, 2005, the Company remained in the development stage. As of March
31, 2005, the Company had assets consisting of cash only in the amount of $395.

As of March 31, 2005, the Company had additional paid in capital of $77,582. The
Company has expended a portion of its cash in furtherance of its business plan,
including primarily expenditure of funds to pay legal and accounting expenses,
and has recorded the full value of the stock issued for services as a general,
selling, and administrative expense. Consequently, the Company's balance sheet
for the quarter ended as of March 31, 2005 reflects a deficit accumulated during
the development stage of ($83,051) and a stockholders deficit of ($2,143), due
to cash advances from shareholders.

Results of Operations

During the period from March 2, 1999 (inception) through March 31, 2005, the
Company has accumulated a deficit of $83,051. During this period, the Company
has engaged in no significant operations other than organizational activities,
acquisition of capital, preparation and filing of the registration of its
securities under the Securities Exchange Act of 1934, as amended, compliance
with its periodical reporting requirements, and efforts to locate a suitable
merger or acquisition candidate. No revenues were received by the Company during
this period.

Plan of Operations and Need for Additional Financing

The Company's plan of operations for most of 2003 and 2004 was to remain dormant
in order to avoid incurring legal and accounting fees related to compliance with
its reporting obligations. However, in the first quarter of 2004, the Company
elected to begin taking the steps necessary to file all delinquent reports and
to once again become current in compliance with its reporting obligations under
the Securities Exchange Act of 1934. As of June 3, 2005, the Company is current
in compliance with its reporting obligations under the Securities Exchange Act
of 1934 once this report is filed.

On March 17, 2005, the Company executed a letter of intent whereby the Company
proposed to exchange shares of the Company for one hundred percent (100%) of the
outstanding shares of Ideal Medical, Inc. d/b/a Integrated Medical Solutions
("IMS"), a Texas corporation.

On March 14, 2005 the Company completed the acquisition of Ideal Medical Inc., a
Texas corporation, pursuant to an Agreement and Plan of Merger. At the effective
time of the merger Ideal Medical Inc. will be merged with and into our wholly
owned subsidiary, OSK Acquisition Corp., a Florida corporation, which will be
subsequently dissolved and merged into the company.
<PAGE>

All of the outstanding shares of Ideal Medical Inc. common stock shall be
converted by virtue of the merger at the Closing Date into shares of our common
stock (the "Merger Securities"). On or before the Closing Date, March 30, 2005,
each Shareholder of Ideal Medical Inc. shall surrender their outstanding shares
of Ideal Medical Inc. common stock existing immediately prior to the Closing
Date. Until surrendered, any outstanding certificates or other documentation
which, prior to the Closing Date represented outstanding shares of Ideal Medical
Inc. common stock, shall be deemed for all corporate purposes to be surrendered.
Upon such surrender, shares of Ideal Medical Inc. common stock so surrendered
shall no longer be outstanding and shall automatically be canceled and retired
and shall cease to exist. Following the completion of the reverse merger
transaction on March 30, 2005, a change of control will occur.

ITEM 3.   EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES

         (a) Evaluation of disclosure controls and procedures. Our chief
executive officer and principal financial officer, after evaluating the
effectiveness of the Company's "disclosure controls and procedures" (as defined
in the Securities Exchange Act of 1934 Rules 13a-14(c) and 15-d-14(c)) as of a
date (the "Evaluation Date") within 90 days before the filing date of this
quarterly report, has concluded that as of the Evaluation Date, our disclosure
controls and procedures were adequate and designed to ensure that material
information relating to us would be made known to him by others within those
entities.

         (b) Changes in internal controls. There were no significant changes in
our internal controls or to our knowledge, in other factors that could
significantly affect our disclosure controls and procedures subsequent to the
Evaluation Date.

<PAGE>

                            PART II OTHER INFORMATION

Item 1.  Legal Proceedings
         Not applicable

Item 2.  Changes in Securities
         Not applicable

Item 3.  Defaults Upon Senior Securities
         Not applicable

Item 4.  Submission of Matters to a Vote of Security Holders

         None.

Item 5.  Other Information
         Not applicable

Item 6.  Exhibits and Reports on Form 8-K

         A. Exhibits:

31.1     Certification of Chief Executive Officer Pursuant to Section 302 of the
         Sarbanes-Oxley Act.

31.2     Certification of Principal Financial and Accounting Officer Pursuant
         to Section 302 of the Sarbanes-Oxley Act.

32.1     Certification of Chief Executive Officer Pursuant to Section 906 of the
         Sarbanes-Oxley Act.

32.2     Certification of Principal Financial and Accounting Officer Pursuant
         to Section 906 of the Sarbanes-Oxley Act.

B. Reports on Form 8-K

            On March 16, 2005, the Company reported that on March 15, 2004,
            Frank Kramer and Deborah Salerno have resigned as officers of the
            Company and have also resigned as members of the Board of Directors
            of the Company. Further to the resignation of Ms. Salerno and Mr.
            Kramer, Francis Mailhot remains the sole director and has been
            nominated as President and CEO of the Company.

            On March 17, 2005, the Company reported that it executed a letter of
            intent whereby the Company proposed to exchange shares of the
            Company for one hundred percent (100%) of the outstanding shares of
            Ideal Medical, Inc. d/b/a Integrated Medical Solutions, a Texas
            corporation.

            On March 18, 2005, the Company reported that it completed the
            acquisition of Ideal Medical Inc., a Texas corporation, pursuant to
            an Agreement and Plan of Merger, the form of which is attached as an
            Exhibit.
<PAGE>

                                   SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange
Act of 1934 the registrant has duly caused this report to be signed on its
behalf by the undersigned, thereunto duly authorized.

                                                            OSK CAPITAL II CORP.

                                                          By /s/ Francis Mailhot
                                     -------------------------------------------
                                                         Chief Executive Officer

                                                             Date: June 16, 2005

                                                           By/s/ Francis Mailhot
                                      ------------------------------------------
                                                        Chief Accounting Officer

                                                             Date: June 16, 2005